⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1401270 | 0.76 | — | — | |
| SCHEMBL11519164 | 0.72 | CA12 (0.35) | — | |
| SCHEMBL27499161 | 0.70 | ALDH1A1 (0.36) | — | |
| SCHEMBL1400993 | 0.67 | CA12 (0.40) | — | |
| SCHEMBL11521795 | 0.66 | DNM1 (0.38) | — | |
| SCHEMBL11519833 | 0.66 | DNM1 (0.38) | — | |
| SCHEMBL11517198 | 0.66 | DNM1 (0.38) | — | |
| SCHEMBL11517386 | 0.66 | DNM1 (0.38) | — | |
| SCHEMBL7367622 | 0.66 | — | — | |
| SCHEMBL7282324 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1239868-A2 | USE OF AN IMMUNOSUPPRESSANT FOR INCREASING AN ANTIFUNGAL ACTIVITY OF A LIPOPETIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-09-18 | — | — | EP | disclosed |
| EP-1223969-A2 | COMBINED USE OF A PLASMINOGEN ACTIVATOR AND IL-2 INHIBITORS FOR NEUROPROTECTION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-07-24 | — | — | EP | disclosed |
| EP-1221938-A2 | METHOD FOR PRODUCING LIPOSOME PREPARATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-07-17 | — | — | EP | disclosed |
| EP-1183028-A2 | NEW USE OF MACROLIDE COMPOUNDS FOR INDUCING CHONDROGENIC DIFFERENTIATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-03-06 | — | — | EP | disclosed |
| EP-1126845-A2 | NEW USE OF IMMUNOSUPPRESSANTS FOR MMP-MEDIATED DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-08-29 | — | — | EP | disclosed |
| WO-2001041780-A2 | USE OF AN IMMUNOSUPPRESSANT FOR INCREASING AN ANTIFUGAL ACTIVITY OF A LIPOPEPTIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-06-14 | — | — | WO | disclosed |
| WO-2001028522-A2 | METHOD FOR PRODUCING LIPOSOME PREPARATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-04-26 | — | — | WO | disclosed |
| EP-1093371-A1 | USE OF FK506 AND RELATED MACROLIDES IN THE MANUFACTURE OF A MEDICAMENT FOR TREATMENT OR PREVENTION OF PAIN | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-04-25 | — | — | EP | disclosed |
| WO-2001026605-A2 | IMMUNOSUPPRESSIVE COMPOSITION CONTAINING IL-2 INHIBITOR AND AN ADENOSINE DEAMINASE INHIBITOR | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-04-19 | — | — | WO | disclosed |
| WO-2001024784-A2 | NEW USE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-04-12 | — | — | WO | disclosed |
| WO-2000074665-A2 | NEW USE OF MACROLIDE COMPOUNDS FOR INDUCING CHONDROGENIC DIFFERENTIATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-12-14 | — | — | WO | disclosed |
| EP-1056454-A1 | USE OF MACROLIDE COMPOUNDS FOR TREATING GLAUCOMA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-12-06 | — | — | EP | disclosed |
| WO-2000015208-A2 | NEW USE OF IMMUNOSUPRESSANTS FOR MMP-MEDIATED DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-03-23 | — | — | WO | disclosed |
| WO-2000007594-A1 | USE OF IL-2 INHIBITORS IN THE TREATMENT OF RHEUMATOID ARTHRITIS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-02-17 | — | — | WO | disclosed |
| WO-2000001385-A1 | USE OF FK506 AND RELATED MACROLIDES IN THE MANUFACTURE OF A MEDICAMENT FOR TREATMENT OR PREVENTION OF PAIN | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-01-13 | — | — | WO | disclosed |
| WO-1999051215-A2 | IMMUNOSUPPRESSIVE IMIDAZOLE DERIVATIVES AND THEIR COMBINATION PREPARATIONS WITH TACROLIMUS OR CYCLOSPORINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-10-14 | — | — | WO | disclosed |
| WO-1999044597-A2 | USE OF MACROLIDE COMPOUNDS FOR THE TREATMENT OF ARDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-09-10 | — | — | WO | disclosed |
| WO-1999042104-A1 | USE OF MACROLIDE COMPOUNDS FOR TREATING GLAUCOMA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-08-26 | — | — | WO | disclosed |
| EP-0851753-A1 | AEROSOL COMPOSITIONS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-07-08 | — | — | EP | disclosed |
| WO-1997010806-A1 | AEROSOL COMPOSITIONS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-03-27 | — | — | WO | disclosed |